Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-14

Clinical Trial Update: Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating potential drug–drug interactions between dihydroartemisinin-piperaquine and antiretroviral therapy in people with HIV; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Drug-Drug Interaction, HIV Infection | Phase 4 | Status: COMPLETED | Results posted: 2025-03-14